In addition, Thiruchelvam et al. [20] reported that ERα is NR5A2(LRH-1) target gene product and Chand and colleagues [21] implicated NR5A2 in promotion of migration and invasion in breast cancer independent of estrogen sensitivity. The gene discussed is ESR1; the disease is breast cancer.